Girihlet Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Seed
  • Investors
  • 4

Girihlet General Information

Description

Developer of a novel patented technology intended to purify and sequence mitochondrial DNA. The company's technology offers a cell sequencing assay that helps to measure the immune system by creating an immune map database to predict and measure a person's health status, enabling researchers to have a significant impact in the clinic and get assisted in advance basic research.

Contact Information

Website
www.girihlet.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • 355 30th street
  • 2945 Webster Street
  • Oakland, CA 94609
  • United States
+1 (510) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Girihlet Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 09-Aug-2018 00.000 Completed Generating Revenue
2. Seed Round 09-Aug-2016 00.00 00.000 00.000 Completed Generating Revenue
1. Accelerator/Incubator 03-Sep-2015 $250K $250K 00.000 Completed Generating Revenue
To view Girihlet’s complete valuation and funding history, request access »

Girihlet Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Girihlet’s complete cap table history, request access »

Girihlet Executive Team (2)

Name Title Board Seat Contact Info
Anitha Jayaprakash Ph.D Co-Founder & Chief Executive Officer
Ravi Sachidanandam Co-Founder & Chief Scientific Officer
To view Girihlet’s complete executive team members history, request access »

Girihlet Board Members (2)

Name Representing Role Since
Adam D'Augelli True Ventures Board Member 000 0000
Stephen Allen Digitalis Ventures Board Observer 000 0000
To view Girihlet’s complete board members history, request access »

Girihlet Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Girihlet Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Digitalis Ventures Venture Capital Minority 000 0000 000000 0
SOSV Venture Capital Minority 000 0000 000000 0
True Ventures Venture Capital Minority 000 0000 000000 0
IndieBio Accelerator/Incubator Minority 000 0000 000000 0
To view Girihlet’s complete investors history, request access »

Ready to get started?

Request a free trial